Professor Sergej M. Ostojic appeared at DoNotAge Conference 2026 with a presentation that placed creatine within the wider discussion of human bioenergetics and healthy ageing rather than limiting it to sports nutrition.
Who is Sergej Ostojic?
Texas Tech University lists Ostojic as a Professor of Nutritional Sciences and describes his research programme as focusing on creatine biology, energy metabolism, molecular hydrogen and translational bioenergetics. DoNotAge also lists him on its Scientific Advisory Board.
What the conference highlights establish
The official DoNotAge Conference 2026 highlights connect Ostojic’s contribution with creatine, cellular bioenergetics and healthy-ageing research. Broader mechanistic themes discussed around creatine should remain separate from clinical claims about slowing ageing or extending lifespan.
Evidence status
Creatine has a substantial evidence base for several exercise and performance outcomes, but that does not automatically establish a clinically meaningful effect on human ageing or lifespan. Mechanistic plausibility, exercise-performance evidence and geroscience outcomes are different evidence categories.
The DoNotAge relationship
Ostojic’s documented relationship with DoNotAge includes his 2026 conference appearance and his current Scientific Advisory Board role. Neither relationship, by itself, should be treated as evidence for a specific product outcome.
Sources
Official DoNotAge Conference 2026 highlights
Texas Tech University — Sergej M. Ostojic profile
DoNotAge.org — Scientific Advisory Board
Return to the 2026 conference hub.
Linked entities and research
DoNotAge Conference 2026
DoNotAge Conference 2026 was held in London on September 26–27, 2026. The official highlights archive presents 12 2026 conversations spanning human trials, DNA repair, inflammation, muscle and exercise, replication and research funding, plus a 2025 conference recap.
Creatine: Beyond Muscles, Into the Brain
Ostojic described creatine as a bioenergetic buffer relevant to muscle and brain function, noted tissue and individual variability, and outlined a 24-week older-adult study of the multi-ingredient DoNotAge Performance formulation. The stated outcome areas include telomere length and physical, functional and metabolic measures; the conference archive also references inflammation, brain function and physical performance.
Sergej M. Ostojic
DoNotAge Scientific Advisory Board member and DoNotAge Conference 2026 speaker. In a DoNotAge video, Ostojic also outlined a planned 24-week older-adult clinical study of the multi-ingredient DoNotAge Performance formulation; the later conference archive described the research as ongoing.